Your browser is no longer supported. Please, upgrade your browser.
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-0.30 Insider Own10.60% Shs Outstand4.16M Perf Week4.23%
Market Cap61.24M Forward P/E- EPS next Y- Insider Trans-2.31% Shs Float3.09M Perf Month-4.95%
Income-1.20M PEG- EPS next Q- Inst Own16.10% Short Float36.88% Perf Quarter212.40%
Sales8.20M P/S7.47 EPS this Y82.20% Inst Trans254.28% Short Ratio0.11 Perf Half Y200.00%
Book/sh2.13 P/B5.32 EPS next Y- ROA-13.50% Target Price- Perf Year583.13%
Cash/sh1.56 P/C7.29 EPS next 5Y15.00% ROE-19.00% 52W Range1.39 - 38.75 Perf YTD258.86%
Dividend- P/FCF- EPS past 5Y74.30% ROI-40.30% 52W High-73.62% Beta3.09
Dividend %- Quick Ratio5.70 Sales past 5Y0.20% Gross Margin73.90% 52W Low635.40% ATR1.41
Employees20 Current Ratio6.30 Sales Q/Q57.10% Oper. Margin-14.50% RSI (14)44.87 Volatility8.40% 13.33%
OptionableNo Debt/Eq0.00 EPS Q/Q54.70% Profit Margin-14.30% Rel Volume0.05 Prev Close11.34
ShortableYes LT Debt/Eq0.00 EarningsJul 22 BMO Payout- Avg Volume9.92M Price10.22
Recom2.00 SMA20-10.10% SMA50-14.42% SMA20084.97% Volume451,414 Change-9.86%
Oct-20-17Reiterated H.C. Wainwright Buy $10 → $3
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
Aug-30-21 07:05AM  
Aug-27-21 12:58PM  
Aug-13-21 03:24PM  
Jul-26-21 09:00AM  
Jul-22-21 07:00AM  
Jul-21-21 04:35AM  
Jul-20-21 02:54PM  
Jul-15-21 09:00AM  
Jun-15-21 09:00AM  
Jun-09-21 11:20AM  
Apr-22-21 07:00AM  
Apr-15-21 01:00PM  
Jan-28-21 07:00AM  
Jan-27-21 03:22AM  
Jan-22-21 11:05AM  
Oct-22-20 07:00AM  
Oct-15-20 11:00AM  
Sep-22-20 07:00AM  
Sep-21-20 01:00PM  
Sep-04-20 07:00AM  
Sep-01-20 01:00PM  
Aug-20-20 02:11PM  
Aug-10-20 10:00AM  
Jul-23-20 07:00AM  
Jul-16-20 03:14PM  
Jul-09-20 01:00PM  
Jun-25-20 01:00PM  
Jun-10-20 06:30PM  
Apr-23-20 07:00AM  
Apr-16-20 01:30PM  
Apr-15-20 09:17AM  
Apr-10-20 01:43PM  
Mar-11-20 11:00AM  
Mar-05-20 12:14PM  
Feb-25-20 01:58PM  
Feb-20-20 09:19AM  
Jan-30-20 04:43AM  
Jan-27-20 07:00AM  
Jan-22-20 10:43AM  
Jan-17-20 12:49PM  
Jan-06-20 01:15PM  
Dec-06-19 09:25AM  
Nov-18-19 11:50AM  
Nov-13-19 09:07AM  
Oct-25-19 08:45AM  
Oct-18-19 07:07AM  
Oct-17-19 07:00AM  
Oct-15-19 11:00AM  
Oct-10-19 11:00AM  
Jul-21-19 11:30PM  
Jul-18-19 07:00AM  
Jul-15-19 09:15AM  
Jul-11-19 01:15PM  
Jun-28-19 07:32AM  
Jun-27-19 07:00AM  
May-21-19 01:00PM  
May-07-19 01:00PM  
May-01-19 11:07PM  
Apr-28-19 10:05AM  
Apr-25-19 07:00AM  
Apr-18-19 10:33AM  
Apr-17-19 11:00AM  
Apr-12-19 10:30AM  
Mar-07-19 11:45AM  
Jan-29-19 01:00PM  
Jan-28-19 11:55AM  
Jan-24-19 07:00AM  
Jan-22-19 01:00PM  
Jan-16-19 01:00PM  
Jan-15-19 02:00PM  
Jan-08-19 01:30PM  
Jan-07-19 07:00AM  
Dec-27-18 01:30PM  
Dec-26-18 02:12PM  
Dec-19-18 01:30PM  
Dec-12-18 01:22PM  
Dec-11-18 01:30PM  
Nov-28-18 11:00AM  
Nov-20-18 10:41AM  
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Japan, China, the Middle East, and Mexico. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is based in Woburn, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HIGGINS THOMAS TSenior Vice President, CFOAug 25Sale10.5550,000527,50023,659Aug 27 05:17 PM
HIGGINS THOMAS TSenior Vice President, CFOAug 23Option Exercise1.5750,00078,50073,659Aug 23 05:24 PM
HIGGINS THOMAS TSenior Vice President, CFOAug 12Sale13.5620,000271,20023,659Aug 13 04:06 PM
Topline Capital Management, LLJun 10Buy3.4228,23896,574570,478Jun 14 06:50 PM
Topline Capital Partners, LP10% OwnerJun 10Buy3.4228,23896,574570,478Jun 14 06:22 PM